Publication | Closed Access
A dose-ranging trial of a matrix transdermal 17β-estradiol for the prevention of bone loss in early postmenopausal women
70
Citations
18
References
1999
Year
Bone DiseaseBone LossBone HealthMatrix Transdermal 17β-EstradiolGynecologyMenopausal Hormone TherapyDose-ranging TrialMenopauseHormone TherapyBone DensityEndocrinologyMedicineOsteoporosisOrthopaedic SurgeryWomen's HealthMenopause Hormone Therapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1